Frontlight ResearchEarly access
Taking people in United StatesNo phase
Genetics of Appendix Cancer Study
Key facts
- Who runs it
- Andreana Holowatyj, PhD, MSCI
- Where
- Nashville, United StatesSee the site
- Trial code
- Status
- Recruiting
- People taking part
- 700 people, planned
- Started
- 11 Nov 2022
- Expected to end
- Nov 2034
- Type of study
- Observational, 3 groups
- Treatments tested
- Genetic profiling
- Retrospective tissue procurement
- Record updated
- 18 April 2025
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 13 criteriaShow less
Who can take part
- GAP Social
- Known diagnosis of appendix cancer in the United States
- Mentally and physically able to consent and participate in the study; GAP Vanderbilt
- Known diagnosis of appendix cancer
- Diagnosed by and/or consulting with a physician/clinical provider participating in the GAP Study
- Mentally and physically able to consent and participate in the study; GAP Parent
- Biological parents (mother and/or father) of individuals actively participating in the GAP Study
- Residing in the United States
- Mentally and physically able to consent and participate in the study
Who cannot take part
- Women pregnant at the time of consent
- Prisoners
- Unable to provide informed consent
- Unable to read, write, or complete questionnaires in English
This trial is currently available in United States.
- Vanderbilt-Ingram Cancer CenterNashville, United StatesContact: GAP Study Coordinator (Rebecca B.)Taking people
About the trial
What the trial wants to find out
The GAP Study is a prospective cohort study designed to comprehensively investigate genetic variations that may contribute to cancer development among individuals diagnosed with appendix/appendiceal cancer who are ages 18+ years.
The 3 groups in the trial
- GAP Social
Individuals ages 18+ years with an appendix cancer diagnosis in the United States.
Treatment: Genetic profiling and Retrospective tissue procurement
- GAP Vanderbilt
Individuals ages 18+ years with an appendix cancer diagnosis seen at Vanderbilt.
Treatment: Genetic profiling and Retrospective tissue procurement
- GAP Parent
Biological parents of active GAP (Social and Vanderbilt) Study participants.
Treatment: Genetic profiling
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Genetics of Appendix Cancer: The GAP Study
- Record updated
- 18 April 2025